<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T09:56:44Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10894828" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10894828</identifier>
        <datestamp>2024-02-27</datestamp>
        <setSpec>bmjgroup</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Arch Dis Child Fetal Neonatal Ed</journal-id>
              <journal-id journal-id-type="iso-abbrev">Arch Dis Child Fetal Neonatal Ed</journal-id>
              <journal-id journal-id-type="hwp">fetalneonatal</journal-id>
              <journal-id journal-id-type="publisher-id">fnn</journal-id>
              <journal-title-group>
                <journal-title>Archives of Disease in Childhood. Fetal and Neonatal Edition</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1359-2998</issn>
              <issn pub-type="epub">1468-2052</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10894828</article-id>
              <article-id pub-id-type="pmcid">PMC10894828</article-id>
              <article-id pub-id-type="pmc-uid">10894828</article-id>
              <article-id pub-id-type="pmid">37907266</article-id>
              <article-id pub-id-type="pmid">37907266</article-id>
              <article-id pub-id-type="publisher-id">fetalneonatal-2023-325871</article-id>
              <article-id pub-id-type="doi">10.1136/archdischild-2023-325871</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-22290178" contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6203-7632</contrib-id>
                  <name>
                    <surname>Clarke</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-45758482" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1820-8718</contrib-id>
                  <name>
                    <surname>Soe</surname>
                    <given-names>Aung</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-65783356" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7657-2588</contrib-id>
                  <name>
                    <surname>Nichols</surname>
                    <given-names>Amy</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-107846184" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0002-1483-4770</contrib-id>
                  <name>
                    <surname>Harizaj</surname>
                    <given-names>Helen</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-58898551" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9169-7592</contrib-id>
                  <name>
                    <surname>Webber</surname>
                    <given-names>Mark A</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-32383257" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3205-6511</contrib-id>
                  <name>
                    <surname>Linsell</surname>
                    <given-names>Louise</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-107846187" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9571-0715</contrib-id>
                  <name>
                    <surname>Bell</surname>
                    <given-names>Jennifer L</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-24264673" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6411-669X</contrib-id>
                  <name>
                    <surname>Tremlett</surname>
                    <given-names>Catherine</given-names>
                  </name>
                  <xref rid="aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib id="author-24229561" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9784-8918</contrib-id>
                  <name>
                    <surname>Muthukumar</surname>
                    <given-names>Priyadarsini</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                </contrib>
                <contrib id="author-59264047" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3495-450X</contrib-id>
                  <name>
                    <surname>Pattnayak</surname>
                    <given-names>Santosh</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-73191077" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5139-3412</contrib-id>
                  <name>
                    <surname>Partlett</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-108200855" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7175-2718</contrib-id>
                  <name>
                    <surname>King</surname>
                    <given-names>Andrew</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-32383347" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5500-2247</contrib-id>
                  <name>
                    <surname>Juszczak</surname>
                    <given-names>Ed</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib id="author-22290024" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7540-7433</contrib-id>
                  <name>
                    <surname>Heath</surname>
                    <given-names>Paul T</given-names>
                  </name>
                  <xref rid="aff7" ref-type="aff">7</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Neonatal Intensive Care Unit</institution>, <institution specific-use="Ringgold_6107">Norfolk and Norwich University Hospitals NHS Foundation Trust</institution>, <addr-line content-type="city">Norwich</addr-line>, <addr-line content-type="state">Norfolk</addr-line>, <country>UK</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">Norwich Medical School</institution>, <institution specific-use="Ringgold_6106">University of East Anglia</institution>, <addr-line content-type="city">Norwich</addr-line>, <addr-line content-type="state">Norfolk</addr-line>, <country>UK</country></aff>
              <aff id="aff3"><label>3</label><institution content-type="department">Neonatal Intensive Care Unit</institution>, <institution specific-use="Ringgold_156480">Medway Maritime Hospital</institution>, <addr-line content-type="city">Gillingham</addr-line>, <addr-line content-type="state">Kent</addr-line>, <country>UK</country></aff>
              <aff id="aff4"><label>4</label><institution specific-use="Ringgold_7308">Quadram Institute Bioscience</institution>, <addr-line content-type="city">Norwich</addr-line>, <addr-line content-type="state">Norfolk</addr-line>, <country>UK</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">National Perinatal Epidemiology Unit, Nuffield Department of Population Health</institution>, <institution specific-use="Ringgold_6396">University of Oxford</institution>, <addr-line content-type="city">Oxford</addr-line>, <country>UK</country></aff>
              <aff id="aff6"><label>6</label><institution content-type="department">Department of Microbiology</institution>, <institution specific-use="Ringgold_6107">Norfolk and Norwich University Hospitals NHS Foundation Trust</institution>, <addr-line content-type="city">Norwich</addr-line>, <addr-line content-type="state">Norfolk</addr-line>, <country>UK</country></aff>
              <aff id="aff7"><label>7</label><institution content-type="department">Centre for Neonatal and Paediatric Infection, Infection and Immunity</institution>, <institution specific-use="Ringgold_4915">Saint George's University of London</institution>, <addr-line content-type="city">London</addr-line>, <country>UK</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Professor Paul Clarke, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, UK; <email>paul.clarke@nnuh.nhs.uk</email>
</corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>3</month>
                <year>2024</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>31</day>
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <volume>109</volume>
              <issue>2</issue>
              <fpage>202</fpage>
              <lpage>210</lpage>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>5</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>08</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.</copyright-statement>
                <copyright-year>2024</copyright-year>
                <ali:free_to_read/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense" start_date="2023-10-31">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="fetalneonatal-2023-325871.pdf"/>
              <abstract>
                <sec>
                  <title>Objective</title>
                  <p>Catheter-related sepsis (CRS) is a major complication with significant morbidity and mortality. Evidence is lacking regarding the most appropriate antiseptic for skin disinfection before percutaneous central venous catheter (PCVC) insertion in preterm neonates. To inform the feasibility and design of a definitive randomised controlled trial (RCT) of two antiseptic formulations, we conducted the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to assess catheter colonisation, sepsis, and skin morbidity.</p>
                </sec>
                <sec>
                  <title>Design</title>
                  <p>Feasibility RCT.</p>
                </sec>
                <sec>
                  <title>Setting</title>
                  <p>Two UK tertiary-level neonatal intensive care units.</p>
                </sec>
                <sec>
                  <title>Patients</title>
                  <p>Preterm infants born &lt;34 weeks’ gestation scheduled to undergo PCVC insertion.</p>
                </sec>
                <sec>
                  <title>Interventions</title>
                  <p>Skin disinfection with either 2% chlorhexidine gluconate (CHG)-aqueous or 2% CHG-70% isopropyl alcohol (IPA) before PCVC insertion and at removal.</p>
                </sec>
                <sec>
                  <title>Primary outcome</title>
                  <p>Proportion in the 2% CHG-70% IPA arm with a colonised catheter at removal.</p>
                </sec>
                <sec>
                  <title>Main feasibility outcomes</title>
                  <p>Rates of: (1) CRS, catheter-associated sepsis (CAS), and CRS/CAS per 1,000 PCVC days; (2) recruitment and retention; (3) data completeness.</p>
                </sec>
                <sec>
                  <title>Safety outcomes</title>
                  <p>Daily skin morbidity scores recorded from catheter insertion until 48 hours post-removal.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>116 babies were randomised. Primary outcome incidence was 4.1% (95% confidence interval: 0.9% to 11.5%). Overall catheter colonisation rate was 5.2% (5/97); CRS 2.3/1000 catheter days; CAS 14.8/1000 catheter days. Recruitment, retention and data completeness were good. No major antiseptic-related skin injury was reported.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>A definitive comparative efficacy trial is feasible, but the very low catheter colonisation rate would make a large-scale RCT challenging due to the very large sample size required. ARCTIC provides preliminary reassurance supporting potential safe use of 2% CHG-70% IPA and 2% CHG-aqueous in preterm neonates.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p><ext-link xlink:href="ISRCTN82571474" ext-link-type="isrctn">ISRCTN82571474</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Infectious Disease Medicine</kwd>
                <kwd>Microbiology</kwd>
                <kwd>Neonatology</kwd>
                <kwd>Sepsis</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="funding-1">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009128</institution-id>
                      <institution>Research for Patient Benefit Programme</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>PB-PG-1013-32076</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float">
              <sec>
                <title>WHAT IS ALREADY KNOWN ON THIS TOPIC</title>
                <list list-type="bullet">
                  <list-item>
                    <p>Good skin disinfection is vital prior to central venous catheterisation to minimise risk of catheter colonisation and subsequent sepsis.</p>
                  </list-item>
                  <list-item>
                    <p>The skin of preterm neonates is particularly vulnerable to antiseptic chemical burn injury.</p>
                  </list-item>
                  <list-item>
                    <p>The most effective antiseptic for reducing risks of both catheter sepsis and skin harms in preterm neonates is unknown due to lacking clinical trial evidence.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>WHAT THIS STUDY ADDS</title>
                <list list-type="bullet">
                  <list-item>
                    <p>The ARCTIC study provides contemporary evidence for rates of catheter-related infections associated with pre-procedural skin disinfection using topical 2% CHG-70% IPA and 2% CHG-aqueous solutions.</p>
                  </list-item>
                  <list-item>
                    <p>Use of 2% CHG-70% IPA for central venous catheterisation in preterm neonates is associated with a very low rate of catheter colonisation at catheter removal.</p>
                  </list-item>
                  <list-item>
                    <p>The robust safety data obtained would support the use of these agents in a large comparative trial, with skin application adhering to strict guidelines.</p>
                  </list-item>
                </list>
              </sec>
              <sec>
                <title>HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY</title>
                <p>The ARCTIC study results provide an accurate indication of the very large sample size that would be needed for a definitive comparative non-inferiority antiseptic trial.</p>
              </sec>
            </boxed-text>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Percutaneous central venous catheters (PCVCs) are essential, but pose a significant risk for bloodstream infection.<xref rid="R1" ref-type="bibr">1–3</xref> Catheter-related and catheter-associated sepsis (CRS and CAS) are dangerous complications that carry significant neonatal morbidity. Sepsis increases intensive care days, antibiotic usage, and risk of adverse neurodevelopmental outcomes and death.<xref rid="R4" ref-type="bibr">4–7</xref>
</p>
              <p>Reducing CRS remains a major goal of the NHS.<xref rid="R8" ref-type="bibr">8</xref> Adoption of catheter care ‘bundles’ helps reduce CRS rates,<xref rid="R9" ref-type="bibr">9 10</xref> but with a multifactorial aetiology the goal of zero CRS still proves elusive.<xref rid="R11" ref-type="bibr">11 12</xref> Individual components of bundles have rarely been rigorously studied through randomised controlled trials (RCTs) in neonates.<xref rid="R3" ref-type="bibr">3 10 12</xref> One crucial component in preventing catheter infection is optimal antiseptic choice for pre-procedural skin disinfection of the catheter insertion site.<xref rid="R2" ref-type="bibr">2 13</xref> Studies in adults, including meta-analysis, show that alcohol-based antiseptics are superior for topical antisepsis.<xref rid="R14" ref-type="bibr">14 15</xref> UK evidence-based guidelines in adults and older children recommend 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (2% CHG-70% IPA),<xref rid="R16" ref-type="bibr">16 17</xref> but they lack guidance on preferred antiseptic in preterm infants, reflecting the paucity of evidence and safety concerns specific to this population.<xref rid="R3" ref-type="bibr">3 13 18</xref> Consequently, multiple different antiseptics, concentrations and combinations are in use in UK neonatal intensive care units (NICUs).<xref rid="R19" ref-type="bibr">19 20</xref>
</p>
              <p>No published RCT has so far examined the safety and efficacy of alcohol-based versus aqueous CHG formulations for skin antisepsis prior to PCVC insertion in preterm neonates. We therefore undertook the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to inform the safety, design and scale of a potential large-scale multicentre RCT to determine whether 2% CHG-aqueous is non-inferior in antiseptic efficacy compared with 2% CHG-70% IPA for skin disinfection prior to PCVC insertion.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2-1">
                <title>Study design and setting</title>
                <p>A blinded parallel group feasibility RCT conducted in two UK tertiary-level NICUs: Norfolk and Norwich University Hospital, and Medway Maritime Hospital.</p>
              </sec>
              <sec id="s2-2">
                <title>Participants</title>
                <p>Preterm infants born at &lt;34 weeks’ gestation were eligible if they required PCVC insertion for parenteral nutrition. We excluded infants: unlikely to survive; with a life-threatening congenital abnormality or an underlying skin condition; who already had an indwelling PCVC or were previously enrolled; with a new episode of suspected sepsis with commencement of antibiotics within the previous 48 hours; with a positive blood culture (BC) within the previous 7 days without a subsequent negative culture.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-3">
                <title>Antiseptic products and blinding</title>
                <p>The two topical Investigational Medicinal Product (IMP) antiseptic agents used, 2% CHG-aqueous and 2% CHG-70% IPA, were specially manufactured under licence for this trial. Production, labelling and blinding of study packs containing paired bottles each containing 20 mL of IMP was as described.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-4">
                <title>Randomisation</title>
                <p>Secure internet-based randomisation was performed as close to catheter insertion as possible by a research team member or trained clinician.<xref rid="R3" ref-type="bibr">3</xref> The randomisation system used stratified block randomisation with allocation sequence generated by the senior trials statistician (LL). Blocks of size 4 and 8 were generated using Stata (V.13/SE for Windows). Stratification was by centre and gestational age at birth (&lt;28 weeks and 28<sup>+0</sup> to 33<sup>+6</sup> weeks). Allocation was weighted 3:1 in favour of the 2% CHG-70% IPA IMP group to inform the primary objective of sample size calculation for a phase-III trial.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-5">
                <title>Interventions</title>
                <p>The trial procedures have been published in detail.<xref rid="R3" ref-type="bibr">3</xref> Trained clinical staff inserted and removed PCVCs according to the trial’s protocol and working good clinical practice guidelines for catheter insertion and removal (<xref rid="SP1 SP2" ref-type="supplementary-material">online supplemental files 1 and 2</xref>). Specimens collected on catheter removal were: (1) two exit site skin swabs (ESSSs), one before and one after skin disinfection of insertion site using the same allocated IMP as at catheter insertion; (2) two ~1 cm long catheter segments, namely the tip plus a proximal segment taken approximately 1-2 cm distal to the former skin entry point; and (3) a peripheral BC (only if catheter removal was for suspected sepsis).<xref rid="R3" ref-type="bibr">3</xref>
</p>
                <supplementary-material id="SP1" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp1</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS1" xlink:href="fetalneonatal-2023-325871supp001.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
                <supplementary-material id="SP2" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp2</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS2" xlink:href="fetalneonatal-2023-325871supp002.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
              </sec>
              <sec id="s2-6">
                <title>Catheter-related sepsis, catheter colonisation and catheter-associated sepsis</title>
                <p>Our study had strict definitions for definite CRS, catheter colonisation and CAS (<xref rid="T1" ref-type="table">table 1</xref>, footnotes).</p>
                <table-wrap position="float" id="T1">
                  <label>Table 1</label>
                  <caption>
                    <p>Summary efficacy outcomes for bacteriology and sepsis including primary outcome</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-70% IPA (n=79)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-aqueous (n=27)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">All (n=106)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Positive exit site skin swab at catheter removal before disinfection, n (%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">11 (15.1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">4 (16.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">15 (15.5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missing</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Positive exit site skin swab at catheter removal after disinfection, n (%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1.4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (4.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missing</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Culture-positive catheter segment at removal†, n (%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (4.1)*</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (8.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">5 (5.2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Positive tip alone</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (3.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (1.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Positive proximal segment alone</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (1.9)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Both tip and proximal segment positive</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (4.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1.0)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missing</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Definite catheter-related sepsis‡, n (%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (4.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.3)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missing</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">13</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">18</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Catheter-associated sepsis§, n (%)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">10 (13.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (12.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">13 (13.4)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Missing</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Total number of PCVC days</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">653</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">223</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">876</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Definite catheter-related sepsis, n (rate per 1000 PCVC days)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (4.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.3)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Catheter-associated sepsis, n (rate per 1000 PCVC days)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">10 (15.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (13.5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">13 (14.8)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T1_FN1">
                      <p>*Primary outcome: 3/73 (4.1%) with 95% confidence interval of 0.9% to 11.5%.</p>
                    </fn>
                    <fn id="T1_FN2">
                      <p>†Catheter colonisation: a catheter that at the time of removal has either one or both segments culture positive.</p>
                    </fn>
                    <fn id="T1_FN3">
                      <p>‡Definite catheter-related sepsis: a peripheral BC plus any catheter segment (i.e. proximal and/or tip) positive with the same organism, based on bacterial culture, antibiotic sensitivity and molecular typing, from a neonate who had an indwelling PCVC and clinical signs of sepsis but no other focus of sepsis.</p>
                    </fn>
                    <fn id="T1_FN4">
                      <p>§Catheter-associated sepsis: clinical signs of sepsis and an accompanying positive BC in the period between catheter insertion and 48 hours post removal but with no other focus of sepsis and with both catheter segment cultures negative.</p>
                    </fn>
                    <fn id="T1_FN5">
                      <p>BC, blood culture; CHG, chlorhexidine gluconate; PCVC, percutaneous central venous catheter.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s2-7">
                <title>Microbiological and molecular analysis</title>
                <p>Catheter segments, skin swabs, and BCs underwent routine culture and antibiotic sensitivities in our hospital microbiology laboratories. Bacterial growths from ESSS cultures were assessed semi-quantitatively.<xref rid="R21" ref-type="bibr">21</xref> Culture-positive isolates were retained for whole genome sequencing, allowing for unequivocal diagnosis of CRS.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-8">
                <title>Outcome measures and assessments</title>
                <sec id="s2-8-1">
                  <title>Primary outcome</title>
                  <p>Proportion of babies in the 2% CHG-70% IPA group with catheter colonisation, determined by at least one of the two catheter segments taken at catheter removal being bacterial culture positive.</p>
                </sec>
                <sec id="s2-8-2">
                  <title>Secondary outcomes</title>
                  <sec id="s2-8-2-1">
                    <title>Efficacy outcomes</title>
                    <p>(1) Proportion of infants with positive ESSSs (pre disinfection and post disinfection) at catheter removal; (2) number and type of culture-positive catheter segments at removal; (3) bacterial species identified on positive BC, ESSSs and catheter segments as typed by molecular methods (undertaken to prove concordance of paired blood and catheter isolates to a species level for definitive diagnosis of definite CRS); (4) proportion of infants with definite CRS in the period between catheter insertion and 48 hours post catheter removal; (5) proportion of infants with CAS in the period between catheter insertion and 48 hours post catheter removal; (6) rate of CRS per 1000 PCVC days; (7) rate of CAS per 1000 PCVC days; (8) rates of recruitment and retention; (9) views of parents and clinicians on factors affecting recruitment and retention; (10) proportion of infants completing the study with complete data for the primary outcome; and (11) proportions of infants with missing data collection forms.</p>
                  </sec>
                  <sec id="s2-8-2-2">
                    <title>Safety outcomes</title>
                    <p>Skin condition and morbidity, assessed at catheter insertion and daily until 48 hours post catheter removal. A validated neonatal contact dermatitis scoring system was used,<xref rid="R22" ref-type="bibr">22</xref> with minor modification.<xref rid="R3" ref-type="bibr">3</xref>
</p>
                  </sec>
                  <sec id="s2-8-2-3">
                    <title>Process outcomes</title>
                    <p>(1) Adherence to study protocol; (2) numbers of attempted and failed catheterisations; and (3) withdrawals.</p>
                  </sec>
                </sec>
              </sec>
              <sec id="s2-9">
                <title>Sample size and statistical analysis</title>
                <p>A target sample size comprising ~93 babies having successfully inserted catheters would suffice to estimate the anticipated incidence of the primary outcome (20%) in the reference 2% CHG-70% IPA group with a 95% CI of 11% to 31%.<xref rid="R3" ref-type="bibr">3</xref> A statistical analysis plan was developed and approved by the Trial Steering Committee (TSC) chair by the end of enrolment (<xref rid="SP3" ref-type="supplementary-material">online supplemental file 3</xref>). This feasibility study is reported in accordance with the Consolidated Standards of Reporting Trials extension guidelines for randomised pilot and feasibility trials.<xref rid="R23" ref-type="bibr">23</xref>
</p>
                <supplementary-material id="SP3" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp3</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS3" xlink:href="fetalneonatal-2023-325871supp003.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
              </sec>
              <sec id="s2-10">
                <title>Data management</title>
                <p>Outcome data were collected as described,<xref rid="R3" ref-type="bibr">3</xref> using study-specific forms. Data were transferred and stored in compliance with Good Clinical Practice (GCP) and Data Protection legislation.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-11">
                <title>Monitoring</title>
                <p>The Sponsor’s nominated representatives undertook regular monitoring visits during the course of the trial, according to a monitoring plan.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-12">
                <title>Pharmacovigilance, data and safety monitoring</title>
                <p>Pharmacovigilance was conducted as described.<xref rid="R3" ref-type="bibr">3</xref> The trial had a Data Monitoring Committee (DMC) and TSC with respective charters signed off by their independent chairs prior to first enrolment. The DMC met regularly before, during and at the end of the trial to review the protocol, compliance, safety and outcome data, including after the first 50 babies were enrolled.<xref rid="R3" ref-type="bibr">3</xref>
</p>
              </sec>
              <sec id="s2-13">
                <title>Patient and public involvement</title>
                <p>The study was developed with extensive parent and public input.<xref rid="R3" ref-type="bibr">3</xref> Two lay TSC parent members assisted dissemination of a final summary report to parents of all participants.</p>
              </sec>
              <sec id="s2-14">
                <title>Ethics and regulatory approvals</title>
                <p>A clinical trial authorisation was granted by the responsible authority on 23rd October 2015 (MHRA reference: 13630/0009/001-0001).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <p>Between March 2017 and July 2018, 207 infants were assessed for eligibility. 116 were randomised of whom 88 were allocated 2% CHG-70% IPA and 28 were allocated 2% CHG-aqueous (<xref rid="F1" ref-type="fig">figure 1</xref>). <xref rid="T2" ref-type="table">Table 2</xref> presents baseline characteristics of all 114 babies who underwent attempted catheterisation. Additional details relating to catheterisation are provided (<xref rid="SP4" ref-type="supplementary-material">online supplemental table S1</xref>).</p>
              <supplementary-material id="SP4" position="float" content-type="local-data">
                <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp4</object-id>
                <label>Supplementary data</label>
                <p>
                  <inline-supplementary-material id="SS4" xlink:href="fetalneonatal-2023-325871supp004.pdf" content-type="local-data"/>
                </p>
              </supplementary-material>
              <fig position="float" id="F1">
                <label>Figure 1</label>
                <caption>
                  <p>Study flow diagram.</p>
                </caption>
                <graphic xlink:href="fetalneonatal-2023-325871f01" position="float"/>
              </fig>
              <table-wrap position="float" id="T2">
                <label>Table 2</label>
                <caption>
                  <p>Infant and maternal baseline characteristics</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <thead>
                    <tr>
                      <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                      <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-70% IPA (n=87)</td>
                      <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-aqueous (n=27)</td>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Centre*, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Norfolk and Norwich</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">56 (64.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">17 (63.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Medway</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">31 (35.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">10 (37.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Male sex, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">46 (52.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">13 (48.1)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Infant’s birth weight (g)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Mean (SD)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1089 (340.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1075 (366.3)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">(508–2150)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">(575–1900)</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> &lt;500 g</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> 500 to 999 g</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">39 (44.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">15 (55.6)</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> 1000 to 1499 g</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">37 (42.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">8 (29.6)</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> ≥1500 g</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">11 (12.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4 (14.8)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Gestational age at birth* (completed weeks)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">28 (26–30)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">28 (26–30)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">(23–32)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">(23–33)</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> &lt;26<sup>+0</sup>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (23.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5 (18.5)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> 26<sup>+0</sup> to 27<sup>+6</sup>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">19 (21.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7 (25.9)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> 28<sup>+0</sup> to 33<sup>+6</sup>
</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">48 (55.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">15 (55.6)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">One of a multiple pregnancy, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">16 (18.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9 (33.3)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Mode of delivery, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Vaginal</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">29 (33.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7 (25.9)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Caesarean</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">58 (66.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (74.1)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Membranes ruptured prior to labour, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">35 (41.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9 (36.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> &gt;24 hours before delivery</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">20 (57.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">6 (66.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> ≤24 hours before delivery</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">15 (42.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">3 (33.3)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Unknown</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Apgar score at 5 minutes</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">8 (7–9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">8 (6–9)</td>
                    </tr>
                    <tr>
                      <td align="char" char="." valign="top" rowspan="1" colspan="1"> &lt;4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2 (2.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2 (7.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">First recorded temperature on admission to NICU after birth, mean (SD) °C</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">36.8 (0.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">36.8 (0.9)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Infant ventilated via an endotracheal tube at the time of randomisation, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">34 (39.1)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">13 (50.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Infant born in recruiting hospital, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">68 (78.2)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">19 (70.4)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Any surgical procedure prior to randomisation, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">6 (6.9)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1 (3.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Prophylactic antifungal medication at the time of randomisation, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">27 (31.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9 (33.3)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Received antibiotics prior to randomisation†, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">78 (98.7)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">26 (96.3)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Devices in situ at time of PCVC insertion†, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Chest drain</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1 (1.3)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Endotracheal tube</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">28 (35.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">12 (44.4)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Peripheral arterial line</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2 (2.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2 (7.4)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Peripheral venous cannula</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">70 (88.6)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">18 (66.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Umbilical arterial catheter</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">24 (30.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">11 (40.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Uumbilical venous catheter</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">43 (54.4)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">14 (51.9)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1"> Other</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">2 (2.5)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Mother’s age (years), mean (SD)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">29.7 (6.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">29.4 (5.7)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Received any antenatal corticosteroids, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">80 (92.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">24 (88.9)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Received antibiotics within the week before delivery, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">27 (31.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">8 (29.6)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Feverish in labour (temperature&gt;38.0°C)‡, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4 (4.8)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0 (0.0)</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Chorioamnionitis suspected clinically before delivery, n (%)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7 (8.0)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1 (3.7)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="T2_FN1">
                    <p>Unless otherwise stated, data are n (%). SD, standard deviation; IQR, interquartile range.</p>
                  </fn>
                  <fn id="T2_FN2">
                    <p>*Stratification factors.</p>
                  </fn>
                  <fn id="T2_FN3">
                    <p>†Data missing for eight cases in the 2% CHG-70% IPA group.</p>
                  </fn>
                  <fn id="T2_FN4">
                    <p>‡Data missing for three cases in the 2% CHG-70% IPA group.</p>
                  </fn>
                  <fn id="T2_FN5">
                    <p>CHG, chlorhexidine gluconate; IPA, isopropyl alcohol; NICU, neonatal intensive care unit; PCVC, percutaneous central venous catheter.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="s3-1">
                <title>Efficacy outcomes</title>
                <sec id="s3-1-1">
                  <title>Clinical and microbiological outcomes including primary outcome</title>
                  <p>One hundred and six babies were assessed for clinical and microbiological outcomes (<xref rid="F1" ref-type="fig">figure 1</xref>). <xref rid="T3" ref-type="table">Table 3</xref> shows individual results for the 31 babies who had at least one positive culture result isolated from culture of blood, ESSSs and catheter segments. Paired catheter segment culture results were available for 97 babies, losses mainly being due to repatriation of neonates to non-participating hospitals before catheter removal. The overall catheter colonisation rate was 5.2% (5/97). Of 79 babies allocated the 2% CHG-70% IPA antiseptic and successfully catheterised, 73 had paired catheter segments available and 3 babies had a colonised catheter at the time of removal, an incidence for the primary outcome of 4.1% (95% CI 0.9% to 11.5%). One baby in each group had definite CRS (2% CHG-70% IPA 1.5% (1/66) vs 2% CHG-aqueous 4.5% (1/22)), and rates of CAS were similar (2% CHG-70% IPA 13.7% vs 2% CHG-aqueous 12.5%). The bacteriology and sepsis-related secondary outcomes are summarised by allocation in <xref rid="T1" ref-type="table">table 1</xref>. At catheter removal, 15 babies (15.5%) overall had a culture-positive ESSS pre-disinfection, with proportions similar between groups, and only one baby in each group had a positive ESSS post-disinfection (<xref rid="T1 T3" ref-type="table">tables 1 and 3</xref>).</p>
                  <table-wrap position="float" id="T3">
                    <label>Table 3</label>
                    <caption>
                      <p>Bacterial species isolated via standard microbiology laboratory culture for infants with at least one positive culture result</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <td align="left" valign="bottom" rowspan="3" colspan="1">ID no</td>
                          <td align="left" valign="bottom" rowspan="3" colspan="1">IMP allocation</td>
                          <td align="left" valign="bottom" colspan="4" rowspan="1">Blood culture(s)</td>
                          <td align="left" valign="bottom" colspan="2" rowspan="1">Exit site skin swab</td>
                          <td align="left" valign="bottom" colspan="2" rowspan="1">Catheter segment</td>
                        </tr>
                        <tr>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Closest to PCVC removal (days)</td>
                          <td align="left" valign="bottom" colspan="3" rowspan="1">Blood culture results</td>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Before disinfection</td>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">After disinfection</td>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Proximal</td>
                          <td align="left" valign="bottom" rowspan="2" colspan="1">Tip</td>
                        </tr>
                        <tr>
                          <td align="left" valign="bottom" rowspan="1" colspan="1">#1</td>
                          <td align="left" valign="bottom" rowspan="1" colspan="1">#2</td>
                          <td align="left" valign="bottom" rowspan="1" colspan="1">#3</td>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">6.2 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.3 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Mixed CoNS<break/>(not specified)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS:<break/>
<italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.0 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. epidermidis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1.8 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.9 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS:<break/>
<italic toggle="yes">S. epidermidis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Mixed CoNS (not specified)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1.3 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: (not specified)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.0 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">12</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">13</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1.4 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS:<break/>
<italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">14*</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.0 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: 1. <italic toggle="yes">S. haemolyticus</italic>; 2. <italic toggle="yes">S. epidermidis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">15†</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1.7 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">16*</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">6.1 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">17</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.2 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">18</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">5.8 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">
                            <italic toggle="yes">CoNS: S. epidermidis</italic>
                          </td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">19</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. warneri</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">20</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.2 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">21</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1. CoNS: <italic toggle="yes">S. capitis</italic>;<break/>2. <italic toggle="yes">S</italic>. <italic toggle="yes">aureus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">22</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: not specified</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Missing‡</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Missing‡</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Missing‡</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">23</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-70% IPA</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">24</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">1.7 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. haemolyticus</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">25</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.0 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. warneri</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">26†</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.3 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. warneri</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. warneri</italic>
</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">27</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. haemolyticus§</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">28</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">29</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">4.0 pre</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">30</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">0.5 post</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: 1. <italic toggle="yes">S. epidermidis</italic>; 2.<break/>
<italic toggle="yes">S. capitis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Missing¶</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">31</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">2% CHG-aqueous</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">–</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">N/A</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. epidermidis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">No growth</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. epidermidis</italic>
</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">CoNS: <italic toggle="yes">S. epidermidis</italic>
</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn id="T3_FN1">
                        <p>*One of two cases of catheter-associated sepsis.</p>
                      </fn>
                      <fn id="T3_FN2">
                        <p>†One of two cases of definite catheter-related sepsis, both paired isolates confirmed via whole genome sequencing.</p>
                      </fn>
                      <fn id="T3_FN3">
                        <p>‡Infant was transferred to a non-participating site where their line was removed.</p>
                      </fn>
                      <fn id="T3_FN4">
                        <p>§Detail of species was not captured in database, but was found post data lock.</p>
                      </fn>
                      <fn id="T3_FN5">
                        <p>¶Sample not obtained.</p>
                      </fn>
                      <fn id="T3_FN6">
                        <p>CoNS, coagulase-negative staphylococcus; ID, identifier; IMP, Investigational Medicinal Product; N/A, not applicable because no blood culture taken between catheter insertion and 48 hours post removal; PCVC, percutaneous central venous catheter; <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Staphylococcus aureus</italic>; <italic toggle="yes">S. capitas</italic>, <italic toggle="yes">Staphylococcus capitis</italic>; <italic toggle="yes">S. epidermidis</italic>, <italic toggle="yes">Staphylococcus epidermidis</italic>; <italic toggle="yes">S. haemolyticus</italic>, <italic toggle="yes">Staphylococcus haemolyticus</italic>; <italic toggle="yes">S. warneri</italic>, <italic toggle="yes">Staphylococcus warneri</italic>.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                  <p>Paired bacterial isolates from relevant babies underwent whole genome sequencing for definitive speciation. Specimens of particular interest were blood and catheter isolates in the two CRS cases (ID numbers 15 and 26, <xref rid="T3" ref-type="table">table 3</xref>), and the blood and ESSS isolates in the two CAS cases (ID numbers 14 and 16, <xref rid="T3" ref-type="table">table 3</xref>). Genome sequencing confirmed identity and exact match of the CoNS species in both the CRS cases. Unfortunately, the paired BC isolates were not retained for the two CAS cases, so their typing and matching was not possible.</p>
                </sec>
                <sec id="s3-1-2">
                  <title>Recruitment, retention and factors affecting</title>
                  <p>Of 178 eligible infants, we approached the parents of 149 and 116 (77.9%) gave consent. The overall retention rate was 83.6% (<xref rid="SP5" ref-type="supplementary-material">online supplemental table S2</xref>). Voluntary feedback collected from parents who declined participation and clinicians’ views on factors affecting recruitment are summarised (<xref rid="SP6" ref-type="supplementary-material">online supplemental table S3</xref>).</p>
                  <supplementary-material id="SP5" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp5</object-id>
                    <label>Supplementary data</label>
                    <p>
                      <inline-supplementary-material id="SS5" xlink:href="fetalneonatal-2023-325871supp005.pdf" content-type="local-data"/>
                    </p>
                  </supplementary-material>
                  <supplementary-material id="SP6" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp6</object-id>
                    <label>Supplementary data</label>
                    <p>
                      <inline-supplementary-material id="SS6" xlink:href="fetalneonatal-2023-325871supp006.pdf" content-type="local-data"/>
                    </p>
                  </supplementary-material>
                </sec>
                <sec id="s3-1-3">
                  <title>Study completion and completeness of data collection</title>
                  <p>The proportion of randomised infants with complete data for the proposed primary outcome of catheter colonisation was 97/116 (83.6%) (<xref rid="SP5" ref-type="supplementary-material">online supplemental table S2</xref>). Completeness of data collection forms was excellent, with only two forms missing (from babies who did not complete the study) (<xref rid="SP7" ref-type="supplementary-material">online supplemental table S4</xref>).</p>
                  <supplementary-material id="SP7" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp7</object-id>
                    <label>Supplementary data</label>
                    <p>
                      <inline-supplementary-material id="SS7" xlink:href="fetalneonatal-2023-325871supp007.pdf" content-type="local-data"/>
                    </p>
                  </supplementary-material>
                </sec>
              </sec>
              <sec id="s3-2">
                <title>Safety outcomes</title>
                <p>One hundred and fourteen babies who received IMP underwent a total of 274 separate skin applications with allocated IMP (2% CHG-70% IPA, n=197; 2% CHG-aqueous n=77), comprising insertion and removal disinfections and applications that preceded failed catheterisation attempts (<xref rid="F1" ref-type="fig">figure 1</xref>; <xref rid="SP5 SP8" ref-type="supplementary-material">online supplemental tables S2 and S5</xref>). Safety data were obtained for all 114 babies (100%) who received allocated antiseptic, including for babies transferred before catheter removal. <xref rid="T4" ref-type="table">Table 4</xref> summarises daily skin morbidity scores in the period between catheter insertion and 48 hours post catheter removal (or post antiseptic application when catheterisation unsuccessful). No baby had any serious or major chemical burn injury or moderate/severe skin reaction recorded or requiring reporting after antiseptic application. A minority showed limited erythema (20/114; 17.5%); this appeared more common if catheterised in the first postnatal days and/or extremely preterm. Seven (6.1%) had limited skin breakdown/excoriation recorded (<xref rid="T4" ref-type="table">table 4</xref>). All skin morbidity was minor, self-limiting and resolved fully. None required special dressing or plastic surgical referral.</p>
                <supplementary-material id="SP8" position="float" content-type="local-data">
                  <object-id pub-id-type="doi">10.1136/archdischild-2023-325871.supp8</object-id>
                  <label>Supplementary data</label>
                  <p>
                    <inline-supplementary-material id="SS8" xlink:href="fetalneonatal-2023-325871supp008.pdf" content-type="local-data"/>
                  </p>
                </supplementary-material>
                <table-wrap position="float" id="T4">
                  <label>Table 4</label>
                  <caption>
                    <p>Daily skin morbidity scores in the period between catheter insertion and 48 hours post catheter removal</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Skin morbidity scores</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-70% IPA (n=87)</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">2% CHG-aqueous (n=27)</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Worst score for skin dryness throughout safety monitoring period</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 1</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">80 (92.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">26 (96.3)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 2</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">7 (8.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (3.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Worst score for erythema throughout safety monitoring period</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 1</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">72 (82.8)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">22 (81.5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 2</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">15 (17.2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">5 (18.5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Worst score for breakdown/excoriation throughout safety monitoring period</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (1–1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(1–2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 1</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">82 (94.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">25 (92.6)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 2</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">5 (5.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (7.4)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Worst score for totals of all three scores throughout safety monitoring period</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Median (IQR)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (3–4)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">3 (3–4)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> Range</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(3–5)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">(3–5)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 3</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">65 (74.7)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">20 (74.1)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 4</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">20 (23.0)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">6 (22.2)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> 5</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">2 (2.3)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">1 (3.7)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"> ≥6</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="3">Scoring was performed at baseline, within 10-30 minutes of catheterisation, and then daily until 48 hours post catheter removal, including for any infants repatriated to another hospital with their PCVC still in situ. Skin integrity scoring was also recorded until 48 hours post antiseptic application in instances where catheterisation proved unsuccessful.<break/>Skin scores were graded as follows:</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"><bold>Dryness</bold><break/>1=Normal, no sign of dry skin<break/>2=Dry skin, visible scaling<break/>3=Very dry skin, cracking/fissures</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"><bold>Erythema</bold><break/>1=No evidence of erythema<break/>2=Visible erythema &lt;50% of skin area exposed to antiseptic<break/>3=Visible erythema ≥50% of skin area exposed to antiseptic</td>
                        <td align="left" valign="top" rowspan="1" colspan="1"><bold>Breakdown/excoriation</bold><break/>1=None evident<break/>2=Small localised areas<break/>3=Extensive</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T4_FN1">
                      <p>CHG, chlorhexidine gluconate; IPA, isopropyl alcohol; IQR, interquartile range; PCVC, percutaneous central venous catheter.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s3-3">
                <title>Process outcomes</title>
                <sec id="s3-3-1">
                  <title>Catheterisation success rate</title>
                  <p>Catheterisation was successful in 106 (93%) of 114 babies who underwent attempted PCVC placement (<xref rid="F1" ref-type="fig">figure 1</xref>). <xref rid="SP8" ref-type="supplementary-material">Online supplemental table S5</xref> shows numbers of anatomical sites having at least one failed catheterisation.</p>
                </sec>
                <sec id="s3-3-2">
                  <title>Adherence to protocol</title>
                  <p>There was good adherence for the intervention (<xref rid="SP8" ref-type="supplementary-material">online supplemental table S5</xref>) and no major protocol breaches.</p>
                </sec>
                <sec id="s3-3-3">
                  <title>Withdrawals</title>
                  <p>There were no study infant withdrawals (<xref rid="F1" ref-type="fig">figure 1</xref>).</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>We successfully carried out a feasibility RCT to compare alcohol versus aqueous formulations of 2% CHG. This is the first RCT to evaluate these formulations specifically for skin disinfection before PCVC insertion in preterm neonates. We have demonstrated a very low primary outcome incidence rate of only 4.1% of catheters being colonised with potentially pathogenic bacteria at the time of removal when 2% CHG-70% IPA antiseptic was used for skin disinfection prior to catheterisation. Furthermore, no major antiseptic-related skin injury was reported after application of either formulation under our strict working guideline. We completed recruitment within a 16-month period and had good rates of compliance with study procedures. Completeness of data collection was excellent, and we gathered rigorous prospective safety data for skin integrity. The primary and all planned secondary objectives were achieved. The ARCTIC trial demonstrates that it would in principle be feasible to conduct a definitive multicentre trial comparing the same two antiseptics in a non-inferiority study.</p>
              <p>Our primary objective was to determine catheter colonisation rate in infants who received 2% CHG-70% IPA, to allow sample size calculation for a definitive efficacy study. Finding the catheter colonisation rate to be only 4.1% gave a much lower event rate than anticipated (~21%) at the outset.<xref rid="R3" ref-type="bibr">3</xref> Modelling sample size for a definitive comparative non-inferiority study using the same primary outcome of catheter colonisation, detection of an absolute risk reduction of 2% would require ~n=3250 infants (90% power, two-sided significance level of 0.05). Assessing a composite clinical outcome of CRS+CAS instead: to detect an absolute risk reduction in catheter infections of 4% (from the combined incidence of CRS+CAS of 15% in our reference group down to 11%), we would need ~n=3400 (allowing for 10% loss-to-follow-up). For a non-inferiority hypothesis (to detect a non-inferiority margin of difference of no less than 4%), ~n=3700 would be needed (allowing for 10% loss-to-follow-up). So, while a definitive trial is feasible, these post hoc sample size calculations indicate that a very large trial would be needed.</p>
              <p>The ~4% catheter colonisation rate seen in the ARCTIC trial reference group was much lower than the ~30% overall rate seen in our previous multicentre study that used much weaker strength (0.015% and 0.05%) CHG antiseptics.<xref rid="R1" ref-type="bibr">1</xref> This sevenfold reduction is probably multifactorial: while the stronger CHG-plus-alcohol combined antiseptic trialled has likely played a major part, it is also likely that the rigorous methodology of catheter insertion and other good catheter care practices helped reduce catheter colonisation. We incorporated such practices into our study protocol to harmonise practices between sites and to maximise compliance with the elements of catheter care ‘bundles’ already collectively known to reduce catheter infection rates.<xref rid="R9" ref-type="bibr">9 10</xref>
</p>
              <p>The main limitation of our feasibility study is from the clinical perspective: the findings are inevitably limited for guiding current clinical practice for preferred antiseptic choice—for that requires a definitive large-scale RCT. Nevertheless, some trial findings may assist current practices. Our low outcome rate (~4%) of catheters colonised at removal after using 2% CHG-70% IPA antiseptic at catheterisation/pre-removal is a rigorous benchmark figure that other centres could reference to audit their own units’ rates of catheter colonisation using the same or other locally preferred antiseptic formulations. We encourage this and suggest that a national audit or registry may provide useful data. Also, our rigorous prospective safety data collected through daily skin monitoring provide preliminary reassurance that both these two ‘stronger’ 2% antiseptic formulations of CHG can be safely applied on the skin of preterm babies if used under similar carefully controlled guidelines (<xref rid="SP1 SP2" ref-type="supplementary-material">online supplemental files 1 and 2</xref>). We therefore propose that both agents merit inclusion in catheter care bundles for preterm babies. Our study adds to the existing but limited RCT evidence base for 2% CHG-70% IPA and 2% CHG-aqueous safety in preterm neonates.<xref rid="R24" ref-type="bibr">24–26</xref> We nevertheless share cautions about their wider use in the first few days postnatal in the lowest gestation babies (&lt;26 weeks) when the burden of skin colonisation is usually lightest yet the risk of chemical injury is greatest.<xref rid="R18" ref-type="bibr">18</xref> It would therefore presently seem prudent to use lower concentration alcohol-free CHG preparations in the first few postnatal days, for example, 0.2% chlorhexidine acetate,<xref rid="R27" ref-type="bibr">27</xref> although accepting the trade-off that rates of catheter sepsis may potentially then be higher.</p>
              <sec id="s4-1">
                <title>Conclusion and future study</title>
                <p>The data from the ARCTIC study suggest that both 2% CHG-aqueous solution and 2% CHG-70% IPA can be used safely in preterm neonates when applied using a strict procedure to limit overexposure. Their use was associated with a large reduction in the risk of catheter colonisation by potentially harmful bacteria compared with historical rates using weaker preparations. A definitive trial is feasible, but based on the very low catheter colonisation rate or combined rate of CRS and CAS, a very large sample size is required. Newer agents such as octenidine<xref rid="R28" ref-type="bibr">28</xref> now require formal evaluation in preterm neonates. But with such low rates of catheter colonisation and sepsis, conducting any definitive efficacy RCT of antiseptics now poses a formidable challenge. Other ways to distinguish between disinfection agents may be needed, such as registry or real-world data-based assessments of safety and efficacy, or else snapshot audits involving a limited number of centres willing to adopt uniform strict protocols and standardised procedures for catheter care and sampling.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <p>We sincerely thank the many parents who assisted this study, particularly Daniel and Louise Davies, Michelle Ashwell, and Rachel Smith for their early enthusiastic support, and all parents who generously allowed their babies to participate. We thank all our nursing and medical colleagues, clinical and research, at both study sites for tremendous support. The CI is very grateful to Jean Craig, Nigel Lambert, Susan Stirling and Prof John Wain for helpful early input into study design, and to Mr Tim White and colleagues at Guy’s &amp; St Thomas’ NHS FT Pharmacy Department, London, UK, for IMP manufacture, packaging, labelling, and IMP Dossier production. We particularly thank Sadie Mitchell and all our microbiology departmental colleagues for their kind support, and Ursula Bowler, Kayleigh Stanbury, David Murray and Pollyanna Hardy of NPEU CTU for help with database, programming and trial management. We very sincerely thank Professors Kate Costeloe (Trial Steering Committee chair) and Mark Turner, (Data Monitoring and Safety Committee chair) and their committee memberships: Nim Subhedar, Catrin Tudur Smith, Vennila Ponnusamy, Sarah Rattigan, Michael Millar and valued lay members Rosemarie Kefford and Natasha London (Trial Steering Committee); Mike Sharland, Victoria Cornelius (Data Monitoring and Safety Committee). PC wishes to acknowledge with gratitude his funding support from NNUH Charitable Fund and UEA MED, and the help and monitoring of Julie Dawson, Francesca Dockerty, Lisa Chalkley and Basia Brown for the sponsor, Tracy Oliver for administrative support, and the NIHR RfPB programme managers for their patience and support. The CI is most grateful to Dr Vennila Ponnusamy, Professor Kate Costeloe, Professor Mark Turner and Pollyanna Hardy for helpful comments on earlier versions of the manuscript, to Dr Jonathan Davis and the Journal’s anonymous reviewers for valuable comments, and Xavier Clarke for proofreading.</p>
            </ack>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Twitter:</bold> @drpaulclarke @ARCTIC_Trial</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Presented at:</bold> These data were previously presented in abstract form at the 8th Congress of the European Academy of Paediatric Societies (EAPS) virtual congress, October 2020.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> PC and PTH conceived the idea for this study. PC designed the study, wrote the protocol and is the chief investigator responsible for all aspects of the study including preparation and submission of the grant application, application for Clinical Trial Authorisation from the Licensing Authority (MHRA), securing funding, obtaining ethics and local NHS approvals, project management and data collection. PTH, CT, LL and EJ contributed to study design and refinement and protocol development. PC, AN, PM, AS, HH and SP undertook patient enrolment and data collection. PC and AS provided research oversight at their sites. MAW was responsible for whole genome sequencing and validation. LL and EJ provided statistical and methodological expertise and JLB assisted in statistical analysis. CP wrote the statistical analysis plan, with input from LL, PC and EJ. AK managed the database, programming and randomisation site. PC wrote the first and final versions of the manuscript. All authors contributed intellectual input and to manuscript revisions, and all approved the final version. PC is the guarantor.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> The ARCTIC Trial was funded by the National Institute for Health Research Research for Patient Benefit Programme (Project ref: PB-PG-1013-32076). The funder provided advice and support and monitored study progress but did not have a role in study design or data collection, analysis and interpretation, or writing of the report. PC also received support for research time from the NNUH Charitable Fund and UEA Medical School.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Disclaimer:</bold> This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-1013-32076). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Supplemental material:</bold> This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p>
              </fn>
            </fn-group>
            <sec sec-type="data-availability">
              <title>Data availability statement</title>
              <p>Data are available upon reasonable request. Reasonable requests for access to the data that support the findings of this study will be considered by contacting the corresponding author.</p>
            </sec>
            <sec sec-type="ethics-statement">
              <title>Ethics statements</title>
              <sec>
                <title>Patient consent for publication</title>
                <p content-type="ethics-consent-to-publish">Not applicable.</p>
              </sec>
              <sec>
                <title>Ethics approval</title>
                <p content-type="ethics-approval">This study involved human participants and had prior approval from the National Health Service Health Research Authority National Research Ethics Service Committee East of England (Cambridge South) (IRAS ID 163868; REC Reference 15/EE/0345). Parents gave prior written informed consent for their infants to participate in the study.</p>
              </sec>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ponnusamy</surname><given-names>V</given-names></string-name>, <string-name><surname>Venkatesh</surname><given-names>V</given-names></string-name>, <string-name><surname>Curley</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2012</year>;<volume>97</volume>:<fpage>F273</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2011-300822</pub-id>
<pub-id pub-id-type="pmid">22174018</pub-id>
</mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ponnusamy</surname><given-names>V</given-names></string-name>, <string-name><surname>Perperoglou</surname><given-names>A</given-names></string-name>, <string-name><surname>Venkatesh</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Skin colonisation at the catheter exit site is strongly associated with catheter colonisation and catheter-related sepsis</article-title>. <source>Acta Paediatr</source><year>2014</year>;<volume>103</volume>:<fpage>1233</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/apa.12779</pub-id>
<pub-id pub-id-type="pmid">25164200</pub-id>
</mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clarke</surname><given-names>P</given-names></string-name>, <string-name><surname>Craig</surname><given-names>JV</given-names></string-name>, <string-name><surname>Wain</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol</article-title>. <source>BMJ Open</source><year>2019</year>;<volume>9</volume>:<elocation-id>e028022</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2018-028022</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stoll</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>NI</given-names></string-name>, <string-name><surname>Adams-Chapman</surname><given-names>I</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection</article-title>. <source>JAMA</source><year>2004</year>;<volume>292</volume>:<fpage>2357</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1001/jama.292.19.2357</pub-id>
<pub-id pub-id-type="pmid">15547163</pub-id>
</mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chau</surname><given-names>V</given-names></string-name>, <string-name><surname>Brant</surname><given-names>R</given-names></string-name>, <string-name><surname>Poskitt</surname><given-names>KJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Postnatal infection is associated with widespread abnormalities of brain development in premature newborns</article-title>. <source>Pediatr Res</source><year>2012</year>;<volume>71</volume>:<fpage>274</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2011.40</pub-id>
<pub-id pub-id-type="pmid">22278180</pub-id>
</mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samarasekara</surname><given-names>SI</given-names></string-name>, <string-name><surname>Booth</surname><given-names>D</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>P</given-names></string-name></person-group>. <article-title>Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infant</article-title>. <source>BMJ Case Rep</source><year>2012</year>;<volume>2012</volume>:<elocation-id>bcr2012007407</elocation-id>. <pub-id pub-id-type="doi">10.1136/bcr-2012-007407</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McGovern</surname><given-names>M</given-names></string-name>, <string-name><surname>Flynn</surname><given-names>L</given-names></string-name>, <string-name><surname>Coyne</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Question 2: does coagulase negative staphylococcal sepsis cause neurodevelopmental delay in preterm infants?</article-title><source>Arch Dis Child</source><year>2019</year>;<volume>104</volume>:<fpage>97</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2018-316004</pub-id>
<pub-id pub-id-type="pmid">30282625</pub-id>
</mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Department of Health</collab></person-group>. <source>Saving Lives: reducing infection, delivering clean and safe care. High Impact Intervention No 1. Central venous catheter care bundle</source>. <year>2007</year>. <comment>Available</comment>: <uri xlink:href="http://webarchive.nationalarchives.gov.uk/20120118164404/hcai.dh.gov.uk/files/2011/03/2011-03-14-HII-Central-Venous-Catheter-Care-Bundle-FINAL.pdf">http://webarchive.nationalarchives.gov.uk/20120118164404/hcai.dh.gov.uk/files/2011/03/2011-03-14-HII-Central-Venous-Catheter-Care-Bundle-FINAL.pdf</uri></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mobley</surname><given-names>RE</given-names></string-name>, <string-name><surname>Bizzarro</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>Central line-associated bloodstream infections in the NICU: successes and controversies in the quest for zero</article-title>. <source>Semin Perinatol</source><year>2017</year>;<volume>41</volume>:<fpage>166</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1053/j.semperi.2017.03.006</pub-id>
<pub-id pub-id-type="pmid">28411947</pub-id>
</mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Payne</surname><given-names>V</given-names></string-name>, <string-name><surname>Hall</surname><given-names>M</given-names></string-name>, <string-name><surname>Prieto</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Care bundles to reduce central line-associated bloodstream infections in the neonatal unit: a systematic review and meta-analysis</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2018</year>;<volume>103</volume>:<fpage>F422</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2017-313362</pub-id>
<pub-id pub-id-type="pmid">29175985</pub-id>
</mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erdei</surname><given-names>C</given-names></string-name>, <string-name><surname>McAvoy</surname><given-names>LL</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Is zero central line-associated bloodstream infection rate sustainable? A 5-year perspective</article-title>. <source>Pediatrics</source><year>2015</year>;<volume>135</volume>:<fpage>e1485</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2014-2523</pub-id>
<pub-id pub-id-type="pmid">25986020</pub-id>
</mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clarke</surname><given-names>P</given-names></string-name>, <string-name><surname>Webber</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Catheter sepsis and Antisepsis: matters of life, death, obscurity and resistance</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2018</year>;<volume>103</volume>:<fpage>F94</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2017-313150</pub-id>
<pub-id pub-id-type="pmid">29371239</pub-id>
</mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ponnusamy</surname><given-names>V</given-names></string-name>, <string-name><surname>Venkatesh</surname><given-names>V</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>P</given-names></string-name></person-group>. <article-title>Skin Antisepsis in the neonate: what should we use?</article-title><source>Curr Opin Infect Dis</source><year>2014</year>;<volume>27</volume>:<fpage>244</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1097/QCO.0000000000000064</pub-id>
<pub-id pub-id-type="pmid">24751895</pub-id>
</mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hibbard</surname><given-names>JS</given-names></string-name>, <string-name><surname>Mulberry</surname><given-names>GK</given-names></string-name>, <string-name><surname>Brady</surname><given-names>AR</given-names></string-name></person-group>. <article-title>A clinical study comparing the skin antisepsis and safety of Chloraprep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine</article-title>. <source>J Infus Nurs</source><year>2002</year>;<volume>25</volume>:<fpage>244</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/00129804-200207000-00007</pub-id>
<pub-id pub-id-type="pmid">12131506</pub-id>
</mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chaiyakunapruk</surname><given-names>N</given-names></string-name>, <string-name><surname>Veenstra</surname><given-names>DL</given-names></string-name>, <string-name><surname>Lipsky</surname><given-names>BA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis</article-title>. <source>Ann Intern Med</source><year>2002</year>;<volume>136</volume>:<fpage>792</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-136-11-200206040-00007</pub-id>
<pub-id pub-id-type="pmid">12044127</pub-id>
</mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pratt</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Pellowe</surname><given-names>CM</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>JA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England</article-title>. <source>J Hosp Infect</source><year>2007</year>;<volume>65 Suppl 1</volume>:<fpage>S1</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/S0195-6701(07)60002-4</pub-id>
<pub-id pub-id-type="pmid">17307562</pub-id>
</mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Loveday</surname><given-names>HP</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Pratt</surname><given-names>RJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England</article-title>. <source>J Hosp Infect</source><year>2014</year>;<volume>86 Suppl 1</volume>:<fpage>S1</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/S0195-6701(13)60012-2</pub-id>
<pub-id pub-id-type="pmid">24330862</pub-id>
</mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Neri</surname><given-names>I</given-names></string-name>, <string-name><surname>Ravaioli</surname><given-names>GM</given-names></string-name>, <string-name><surname>Faldella</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Chlorhexidine-induced chemical burns in very low birth weight infants</article-title>. <source>J Pediatr</source><year>2017</year>;<volume>191</volume>:<fpage>262</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2017.08.002</pub-id>
<pub-id pub-id-type="pmid">29173315</pub-id>
</mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heron</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Faraday</surname><given-names>CM</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>P</given-names></string-name></person-group>. <article-title>The hidden harms of Matching Michigan</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2013</year>;<volume>98</volume>:<fpage>F466</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2013-304378</pub-id>
<pub-id pub-id-type="pmid">23749052</pub-id>
</mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fraser</surname><given-names>C</given-names></string-name>, <string-name><surname>Harron</surname><given-names>K</given-names></string-name>, <string-name><surname>Dalton</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales</article-title>. <source>PLoS One</source><year>2018</year>;<volume>13</volume>:<elocation-id>e0204894</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0204894</pub-id><pub-id pub-id-type="pmid">30383769</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maki</surname><given-names>DG</given-names></string-name>, <string-name><surname>Weise</surname><given-names>CE</given-names></string-name>, <string-name><surname>Sarafin</surname><given-names>HW</given-names></string-name></person-group>. <article-title>A semiquantitative culture method for identifying intravenous-catheter-related infection</article-title>. <source>N Engl J Med</source><year>1977</year>;<volume>296</volume>:<fpage>1305</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM197706092962301</pub-id>
<pub-id pub-id-type="pmid">323710</pub-id>
</mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lund</surname><given-names>CH</given-names></string-name>, <string-name><surname>Osborne</surname><given-names>JW</given-names></string-name></person-group>. <article-title>Validity and reliability of the neonatal skin condition score</article-title>. <source>J Obstet Gynecol Neonatal Nurs</source><year>2004</year>;<volume>33</volume>:<fpage>320</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/0884217504265174</pub-id>
</mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eldridge</surname><given-names>SM</given-names></string-name>, <string-name><surname>Chan</surname><given-names>CL</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>MJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>CONSORT 2010 statement: extension to randomised pilot and feasibility trials</article-title>. <source>BMJ</source><year>2016</year>;<volume>355</volume>:<elocation-id>i5239</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmj.i5239</pub-id><pub-id pub-id-type="pmid">27777223</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kieran</surname><given-names>EA</given-names></string-name>, <string-name><surname>O’Sullivan</surname><given-names>A</given-names></string-name>, <string-name><surname>Miletin</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2018</year>;<volume>103</volume>:<fpage>F101</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2016-312193</pub-id>
<pub-id pub-id-type="pmid">29074717</pub-id>
</mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jain</surname><given-names>A</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>P</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>EW</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>2% aqueous vs alcohol-based chlorhexidine for skin antisepsis in VLBW neonates undergoing peripheral venipuncture: a non-inferiority trial</article-title>. <source>J Perinatol</source><year>2022</year>;<volume>42</volume>:<fpage>636</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/s41372-022-01337-1</pub-id>
<pub-id pub-id-type="pmid">35184146</pub-id>
</mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sharma</surname><given-names>A</given-names></string-name>, <string-name><surname>Kulkarni</surname><given-names>S</given-names></string-name>, <string-name><surname>Thukral</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2021</year>;<volume>106</volume>:<fpage>643</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2020-321174</pub-id>
<pub-id pub-id-type="pmid">34108192</pub-id>
</mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janssen</surname><given-names>LMA</given-names></string-name>, <string-name><surname>Tostmann</surname><given-names>A</given-names></string-name>, <string-name><surname>Hopman</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: a preliminary report</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source><year>2018</year>;<volume>103</volume>:<fpage>F97</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1136/archdischild-2017-312694</pub-id>
<pub-id pub-id-type="pmid">28468901</pub-id>
</mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bührer</surname><given-names>C</given-names></string-name>, <string-name><surname>Bahr</surname><given-names>S</given-names></string-name>, <string-name><surname>Siebert</surname><given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation</article-title>. <source>J Hosp Infect</source><year>2002</year>;<volume>51</volume>:<fpage>305</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1053/jhin.2002.1249</pub-id>
<pub-id pub-id-type="pmid">12183146</pub-id>
</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
